BridgeBio Pharma LLC and Cincinnati Children’s Hospital Medical Center have entered into a research collaboration to identify and develop genetic disease therapies. This partnership will combine BridgeBio’s therapeutic development expertise with Cincinnati Children’s world-class researchers and clinicians. BridgeBio will have the opportunity to sponsor and collaboratively develop selected research programs. The agreement represents a flexible model that facilitates accelerat...